NCT05307874 2025-12-24
EVICTION-2
ImCheck Therapeutics
Phase 1/2 Completed
Clinical Trials
4 trialsNCT04597541 2025-03-10
A Study of AK112 for Advanced Solid Tumors
Akeso
Phase 1/2 Completed
NCT04020185 2024-12-11
Safety and Efficacy Study of IMSA101 in Refractory Malignancies
ImmuneSensor Therapeutics Inc.
Phase 1/2 Completed
NCT04121442 2024-08-06
Isunakinra Alone and in Combination With a PD-1/PD-L1 Inhibitor in Patients With Solid Tumors
Buzzard Pharmaceuticals
Phase 1/2 Completed